These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018 [TBL] [Abstract][Full Text] [Related]
24. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085 [TBL] [Abstract][Full Text] [Related]
25. Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis. Kim TJ; Lee JS; Yoon JS; Oh MS; Kim JW; Park SH; Jung KH; Kim HY; Kwon JH; Choi HY; Kim HY; Eah KY; Han SW; Oh HG; Kim YJ; Shin BS; Kim CH; Kim CK; Park JM; Lee KB; Park TH; Lee J; Park MS; Choi JC; Kim C; Shin DI; Lee SJ; Kim DE; Cha JK; Kim EG; Yu KH; Hong KS; Lee YS; Lee JH; Sohn SI; Bae HJ; Lee YB; Lee JH; Rha JH; Lee BC; Chang DI; Ko SB; Yoon BW Int J Stroke; 2023 Aug; 18(7):812-820. PubMed ID: 36748980 [TBL] [Abstract][Full Text] [Related]
26. Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome. Lv WH; Dong JZ; Du X; Hu R; He L; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Chen X; Cui YK; Tang RB; Ma CS J Thromb Thrombolysis; 2022 May; 53(4):868-877. PubMed ID: 34677727 [TBL] [Abstract][Full Text] [Related]
27. Management of stable coronary artery disease and atrial fibrillation with anti-thrombotic therapy: A systematic review and meta-analysis. Malladi S; Hamid K; Pendyala NC; Veerapaneni V; Deliwala S; Dubre D; Elian SA; Singh A Medicine (Baltimore); 2021 Dec; 100(48):e27498. PubMed ID: 35049165 [TBL] [Abstract][Full Text] [Related]
28. Antithrombotic Therapy for Atrial Fibrillation and Coronary Artery Disease in Patients With Prior Atherothrombotic Disease: A Post Hoc Analysis of the AFIRE Trial. Matsuzawa Y; Kimura K; Yasuda S; Kaikita K; Akao M; Ako J; Matoba T; Nakamura M; Miyauchi K; Hagiwara N; Hirayama A; Matsui K; Ogawa H; J Am Heart Assoc; 2021 Nov; 10(21):e020907. PubMed ID: 34658247 [TBL] [Abstract][Full Text] [Related]
29. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial. Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials. Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289 [TBL] [Abstract][Full Text] [Related]
31. [Current use of oral anticoagulation therapy and influencing factors among coronary artery disease patients with nonvalvular atrial fibrillation in China]. Qiao Y; Wang Y; Li SN; Jiang CX; Sang CH; Tang RB; Long DY; Wu JH; He L; Du X; Dong JZ; Ma CS Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):504-512. PubMed ID: 37198122 [No Abstract] [Full Text] [Related]
32. Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry. Chandrasekhar J; Mastoris I; Baber U; Sartori S; Schoos M; Bansilal S; Dangas G; Mehran R Am Heart J; 2015 Dec; 170(6):1234-42. PubMed ID: 26678646 [TBL] [Abstract][Full Text] [Related]
33. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting. Lacoste JL; Hansen CL Am J Health Syst Pharm; 2019 Sep; 76(18):1395-1402. PubMed ID: 31505555 [TBL] [Abstract][Full Text] [Related]
34. Anticoagulation With or Without Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement for Patients With Atrial Fibrillation: A Meta-Analysis. Yokoyama Y; Briasoulis A; Takagi H; Kuno T Cardiovasc Revasc Med; 2021 Mar; 24():42-47. PubMed ID: 32830088 [TBL] [Abstract][Full Text] [Related]
35. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion. Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779 [TBL] [Abstract][Full Text] [Related]
36. Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study. Otsuki H; Yamaguchi J; Kamishima K; Arashi H; Hagiwara N Heart Vessels; 2018 Sep; 33(9):986-996. PubMed ID: 29549436 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of antithrombotic regimens after coronary intervention in patients on oral anticoagulation: Traditional and Bayesian meta-analysis of clinical trials. Liu J; Fan M; Zhao J; Zhao B; Zhang C; Liu C; Dong Y Int J Cardiol; 2016 Feb; 205():89-96. PubMed ID: 26724753 [TBL] [Abstract][Full Text] [Related]